0 Comments
0 Shares
158 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Forecast 2026–2034: Growth Driven by Rising Antimicrobial Resistance and Advanced Antibiotic InnovationsGlobal Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market continues to demonstrate robust growth amid rising antimicrobial resistance and increasing prevalence of hard-to-treat skin infections. Healthcare providers worldwide are facing significant challenges in managing deep tissue infections, surgical site complications, and diabetic foot ulcers - all of which require advanced...0 Comments 0 Shares 315 Views 0 Reviews
-
Phage Therapy for Antibiotic Resistance Market Size, Next-Generation Antimicrobial Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Phage Therapy for Antibiotic Resistance Market The global phage therapy for antibiotic resistance market size was valued at USD 313.63 million in 2024 and is expected to reach USD 1,116.44 million by 2032, at a CAGR of 17.20% during the forecast period The data, information,...0 Comments 0 Shares 341 Views 0 Reviews
-
Phage Therapy for Antibiotic Resistance Market Size, Next-Generation Antimicrobial Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Phage Therapy for Antibiotic Resistance Market The global phage therapy for antibiotic resistance market size was valued at USD 313.63 million in 2024 and is expected to reach USD 1,116.44 million by 2032, at a CAGR of 17.20% during the forecast period The data, information,...0 Comments 0 Shares 366 Views 0 Reviews
-
Tackling Antimicrobial Resistance (AMR): Market Dynamics and Novel Anti-Infective Innovations (2026–2033)The global healthcare landscape is witnessing critical structural transformations, placing infectious disease management at the center of clinical priorities. According to recent comprehensive industry tracking, the global Anti-Infective Drugs Market—which was valued at USD 135 billion in 2022 and climbed toward USD 184.7 billion by 2030—is maintaining an architectural shift in...0 Comments 0 Shares 90 Views 0 Reviews
-
The Antimicrobial Resistance Challenge: How the Clostridium Difficile Associated Disease Market Is RespondingClostridium difficile (C. diff) is a bacterium that causes a potentially life-threatening gastrointestinal infection, typically triggered by the disruption of normal gut flora following antibiotic use. The rising incidence of these infections, coupled with growing antibiotic resistance and high recurrence rates, represents a significant public health challenge. The Clostridium Difficile...0 Comments 0 Shares 79 Views 0 Reviews
-
UK Antibiotic Resistance Market - NHS Antimicrobial Stewardship Achieving National CoverageMarket Overview The UK antibiotic resistance market is maturing as NHS antimicrobial stewardship achieves national coverage across English healthcare trusts and devolved nation health services. The UK Antibiotic Resistance Market is projected to grow through 2030, driven by increasing NHS England AMS mandates, growing integration of stewardship in CQUIN frameworks, rising complexity of...0 Comments 0 Shares 171 Views 0 Reviews
-
Bacterial Vaccines Market to Hit $47.93 Billion by 2032.Introspective Market Research (IMR) today unveiled a comprehensive analysis of the Global Bacterial Vaccines Market, forecasting a monumental rise in demand over the next decade. According to the report, the market was valued at USD 23.78 billion in 2023 and is projected to reach USD 47.93 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.10% from 2024 to 2032. This surge is...0 Comments 0 Shares 5K Views 0 Reviews
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 778 Views 0 Reviews
-
Clinical Microbiology Market - Size & Industry AnalysisIntrospective Market Research, a leading authority in healthcare and life sciences market intelligence, today published its comprehensive analysis of the Global Clinical Microbiology Market. This vital sector encompasses diagnostic instruments, reagents, and automated systems used for the identification, isolation, and susceptibility testing of infectious pathogens, playing a pivotal role in...0 Comments 0 Shares 4K Views 0 Reviews
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Comments 0 Shares 1K Views 0 Reviews
-
Respiratory Tract Infection Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) has released a critical analysis of the Global Respiratory Tract Infection (RTI) Treatment Market, highlighting its rapid expansion fueled by persistent global health challenges. RTIs, including pneumonia, bronchitis, and sinusitis, remain a leading cause of morbidity and mortality worldwide. The market, which was valued at USD 40.20 Billion in 2023, is...0 Comments 0 Shares 4K Views 0 Reviews
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Comments 0 Shares 2K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali